ongitudinal serological study of SARS-CoV-2 positive individuals
Not Applicable
- Conditions
- 07.1
- Registration Number
- DRKS00028057
- Lead Sponsor
- KH Labor GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
In addition to the signed declaration of consent, the prerequisite for participation is the clinical suspicion of an infection with SARS-CoV-2.
Exclusion Criteria
Exclusion criteria are: Primary immunodeficiency, severe liver or kidney disease, test persons taking immunomodulating medication, pregnant women and persons suffering from an oncological disease.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypothesis: The severity of the disease after infection with SARS-CoV-2 influences the number and quality of detectable antibodies against SARS-CoV-2.
- Secondary Outcome Measures
Name Time Method The immune system of sick people reacts individually to SARS-CoV-2 with regard to the humoral immune response.